Eiger BioPharmaceuticals Inc (NASDAQ:EIGR)
| 1.42 Delayed Data As of Jan 27 |  -0.01 / -0.70%Today’s Change | 0.96 Today|||52-Week Range 10.02 | +20.34% Year-to-Date |
Latest EIGR News | Press Releases
| Top 5 4th Quarter Trades of Trellus Management Company, LLC Jan 27 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 1.43 |
| Today’s open | 1.40 |
| Day’s range | 1.38 - 1.43 |
| Volume | 18,043 |
| Average volume (3 months) | 753,464 |
| Market cap | $59.1M |
Data as of 3:59pm ET, 01/27/2023
Growth & Valuation
| Earnings growth (last year) | +56.77% |
| Earnings growth (this year) | -121.64% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 14.51 |
| Price/Book | 0.67 |
Competitors
Data as of 3:59pm ET, 01/27/2023
Financials
| Next reporting date | March 16, 2023 |
| EPS forecast (this quarter) | -$0.53 |
| Annual revenue (last year) | $12.1M |
| Annual profit (last year) | -$33.9M |
| Net profit margin | -279.34% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Palo Alto, California |
Forecasts
